| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 00% | ₹213.05 0% | 760 | ₹4.4 0% | 00% |
| 00% | ₹195.2 0% | 780 | ₹0.85 6.24% | 20,1504% |
| 00% | ₹177.95 0% | 800 | ₹0.95 0% | 62,775-6.89% |
| 00% | ₹150.5 0% | 810 | ₹6.6 0% | 00% |
| 00% | ₹161.35 0% | 820 | ₹2 0% | 3,8750% |
| 1,5500% | ₹89.05 0% | 830 | ₹2 0% | 3,1000% |
| 00% | ₹145.5 0% | 840 | ₹3 0% | 20,1504% |
| 9,3000% | ₹61 -11.59% | 850 | ₹3.15 0% | 68,9750% |
| 00% | ₹60 0% | 860 | ₹5.5 10% | 1,30,200522.22% |
| 00% | ₹102.65 0% | 870 | ₹7.45 23.14% | 51,15060.97% |
| 7,7500% | ₹45.45 0.33% | 880 | ₹9.8 28.94% | 1,72,8254.69% |
| 3,8750% | ₹32.25 0% | 890 | ₹13.4 39.58% | 37,975-2% |
| 1,74,3750% | ₹23.95 -20.69% | 900 | ₹17.7 35.63% | 3,20,85022.84% |
| 1,54,22528.38% | ₹19.2 -18.29% | 910 | ₹22.2 29.44% | 81,375-13.93% |
| 1,87,5502.54% | ₹14.7 -19% | 920 | ₹26.4 15.53% | 1,54,2250% |
| 1,41,0505.81% | ₹11.6 -17.14% | 930 | ₹33.85 27.01% | 44,9500% |
| 1,75,150-1.31% | ₹8.35 -22.68% | 940 | ₹37 0% | 32,5500% |
| 3,03,800-1.25% | ₹6.5 -18.75% | 950 | ₹43 3.61% | 88,3500% |
| 76,725-10.81% | ₹4.6 -22.68% | 960 | ₹53 0% | 12,4000% |
| 43,4000% | ₹3.6 -21.73% | 970 | ₹56.8 0% | 1,5500% |
| 88,3502.70% | ₹2.7 -14.28% | 980 | ₹71.65 33.05% | 6,9750% |
| 16,2755% | ₹2.15 -23.21% | 990 | ₹71.35 0% | 00% |
| 1,59,6502.48% | ₹1.9 0% | 1,000 | ₹85.7 0% | 26,3500% |
| 00% | ₹30.3 0% | 1,010 | ₹84.35 0% | 00% |
| 37,2000% | ₹1.35 0% | 1,020 | ₹91.65 0% | 00% |
| 00% | ₹24.5 0% | 1,030 | ₹98.35 0% | 00% |
| 11,6250% | ₹0.7 0% | 1,040 | ₹104.75 0% | 00% |
| - | - | 1,050 | ₹136.25 0% | 7,7500% |
| 00% | ₹31.9 0% | 1,060 | ₹118.7 0% | 00% |
| 2,3250% | ₹0.7 0% | 1,080 | - | - |
| 6,9750% | ₹0.4 -11.11% | 1,100 | ₹177 0% | 4,6500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
